[HTML][HTML] Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer
B Zhan, S Wen, J Lu, G Shen, X Lin, J Feng, H Huang - Oncotarget, 2017 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal tumors. However, the
methodological differences between orthotopic and subcutaneous xenograft (OX and SX) …
methodological differences between orthotopic and subcutaneous xenograft (OX and SX) …
Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer
M Schiavone, E Rampazzo, A Casari… - Disease models & …, 2014 - journals.biologists.com
Pancreatic adenocarcinoma, one of the worst malignancies of the exocrine pancreas, is a
solid tumor with increasing incidence and mortality in industrialized countries. This condition …
solid tumor with increasing incidence and mortality in industrialized countries. This condition …
Expanding the spectrum of pancreatic cancers responsive to vesicular stomatitis virus-based oncolytic virotherapy: challenges and solutions
MC Holbrook, DW Goad, VZ Grdzelishvili - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy
with a poor prognosis and a dismal survival rate. Oncolytic virus (OV) is an anticancer …
with a poor prognosis and a dismal survival rate. Oncolytic virus (OV) is an anticancer …
Heterodimeric RGD-NGR PET tracer for the early detection of pancreatic cancer
Purpose Pancreatic ductal adenocarcinoma (PDAC) is the most lethal gastrointestinal
cancer, and its poor prognosis is highly associated with the lack of an efficient early …
cancer, and its poor prognosis is highly associated with the lack of an efficient early …
DNA polymerase theta plays a critical role in pancreatic cancer development and metastasis
A Smolinska, K Singer, J Golchert, U Smyczynska… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the most deadly
cancers worldwide. The occurrence of oncogenic KRAS mutations is considered a signature …
cancers worldwide. The occurrence of oncogenic KRAS mutations is considered a signature …
Lipopolysaccharide‐induced hypothalamic inflammation in cancer cachexia‐anorexia is amplified by tumour‐derived prostaglandin E2
X Li, T Holtrop, FAC Jansen, B Olson… - Journal of cachexia …, 2022 - Wiley Online Library
Background Cachexia‐anorexia syndrome is a complex metabolic condition characterized
by skeletal muscle wasting, reduced food intake and prominent involvement of systemic and …
by skeletal muscle wasting, reduced food intake and prominent involvement of systemic and …
Identification of Ppy‐lineage cells as a novel origin of pancreatic ductal adenocarcinoma
OB Pereye, Y Nakagawa, T Sato… - The Journal of …, 2024 - Wiley Online Library
The Ppy gene encodes pancreatic polypeptide (PP) secreted by PP‐or γ‐cells, which are a
subtype of endocrine cells localised mainly in the islet periphery. For a detailed …
subtype of endocrine cells localised mainly in the islet periphery. For a detailed …
[HTML][HTML] Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment
Y Zhang, Y Yao, H Wang, Y Guo… - Chinese Journal of …, 2013 - ncbi.nlm.nih.gov
Objective To test the effects of salidroside on formation and growth of glioma together with
tumor microenvironment. Methods Salidroside extracted from Rhodiola rosea was purified …
tumor microenvironment. Methods Salidroside extracted from Rhodiola rosea was purified …
TSPO-targeted PET and optical probes for the detection and localization of premalignant and malignant pancreatic lesions
Purpose: Pancreatic cancer is among the most aggressive malignancies and is rarely
discovered early. However, pancreatic “incidentalomas,” particularly cysts, are frequently …
discovered early. However, pancreatic “incidentalomas,” particularly cysts, are frequently …
[HTML][HTML] Constitutively active Akt1 cooperates with KRasG12D to accelerate in vivo pancreatic tumor onset and progression
Abstract BACKGROUND AND AIMS: Pancreatic adenocarcinoma is a deadly disease
characterized by metastatic progression and resistance to conventional therapeutics …
characterized by metastatic progression and resistance to conventional therapeutics …